Bristol-Myers Squibb Company Ce
CELG-RINYSEHealthcare● Active
$0.10
$-0.02(-16.85%)
Market Cap$203594379
P/E Ratio—
52W High$0.1229
52W Low$0.0997
Bristol-Myers Squibb Company Ce (CELG-RI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CELG-RI · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2018-12 | 2017-12 | 2016-12 | 2015-12 | 2014-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $15.28B | $13.00B | $11.23B | $9.26B | $7.67B |
| Cost of Revenue | $0.59B | $0.46B | $0.44B | $0.42B | $0.39B |
| Gross Profit | $14.69B | $12.54B | $10.79B | $8.84B | $7.28B |
| Gross Margin %(computed) | 96.16% | 96.45% | 96.10% | 95.46% | 94.97% |
| Operating Expenses | |||||
| R&D Expenses | $5.67B | $5.92B | $4.47B | $3.70B | $2.43B |
| G&A Expenses | $3.25B | $2.94B | $2.66B | $2.31B | $2.03B |
| Total Operating Expenses | $8.92B | $8.86B | $7.13B | $6.00B | $4.46B |
| Operating Income | $5.19B | $4.71B | $3.17B | $2.25B | $2.52B |
| Operating Margin %(computed) | 33.97% | 36.20% | 28.20% | 24.36% | 32.84% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.74B | $0.52B | $0.50B | $0.31B | $0.18B |
| Income Before Tax | $4.83B | $4.31B | $2.37B | $2.02B | $2.33B |
| Income Tax Expense | $0.79B | $1.37B | $0.37B | $0.42B | $0.33B |
| Net Income | $4.05B | $2.94B | $2.00B | $1.60B | $2.00B |
| Net Margin %(computed) | 26.48% | 22.61% | 17.80% | 17.31% | 26.07% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $5.51 | $3.77 | $2.57 | $2.02 | $2.49 |
| Wtd Avg Shares | 0.73B | 0.78B | 0.78B | 0.79B | 0.80B |
| EBITDA | $6.21B | $5.31B | $3.38B | $2.74B | $2.88B |
| EBITDA Margin %(computed) | 40.63% | 40.81% | 30.08% | 29.63% | 37.51% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Bristol-Myers Squibb Company Ce data
About Bristol-Myers Squibb Company Ce (CELG-RI) Income Statement
Bristol-Myers Squibb Company Ce (CELG-RI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2018, CELG-RI reported revenue of $15.28B, gross profit of $14.69B (gross margin 96.16%), and net income of $4.05B — a net profit margin of 26.48%.
Frequently asked questions
CELG-RI · 4 questionsBristol-Myers Squibb Company Ce (CELG-RI) reported revenue of $15.28B for 2018, up 17.5% year-over-year.
CELG-RI revenueCELG-RI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08